Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COZAAR Plus in Essential Hypertension
NCT00449111Phase 3Terminated
- Sponsor
- Organon & Co.
- Start
- Mar 2006
- Primary completion
- Sep 2006
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of losartan and hydrochlorothiazide in essential hypertension, sponsored by Organon & Co. Primary endpoint: Change of diastolic blood pressure at 6 weeks. Started Mar 2006; status: terminated.
02
Drugs
losartanhydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00449111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00449111.